Recall Ready? What the 2026 Baby Formula crisis means for every Food Manufacturer

Across late 2025 and early 2026, two major baby formula recalls shook consumer confidence on both sides of the Atlantic.

In January 2026, food manufacturer Nestlé issued a precautionary recall of multiple SMA Infant and Follow-On Formula products over the possible presence of Cereulide - a toxin that is more commonly found in foods like re-heated rice and pasta, and which causes food poisoning. In February, Danone, who make Aptamil and Cow & Gate brands, issued a similar recall.

Meanwhile, in the US, ByHeart Whole Nutrition Infant Formula was recalled following a multi-state outbreak of infant botulism that ultimately hospitalized 48 infants.

Certainly, it’s been a bad year to be a baby formula manufacturer - but are these isolated events or a stress-test of the systems every food business relies on?

The recalls in detail

In its biggest product recall to date, food giant Nestle withdrew many of its SMA infant and follow-on formulas from sale in the UK (as well as Beba, Guigoz, and Alfamino brands internationally) over concerns about a possible contamination with Cereulide, a toxin that can cause nausea, vomiting and abdominal cramps.

Food manufacturer Danone, the makers of Aptamil and Cow & Gate brands, also issued a recall in February 2026, pointing to possible supply chain woes across many of the UK’s infant formula manufacturers.

36 infants in the UK had suspected food poisoning from the contaminated formula, though none were seriously ill.

In the US, manufacturer ByHeart recalled its formula after 28 confirmed and 20 probable cases of infant botulism resulted in hospitalization of babies - the first case of the illness linked to formula.

The contamination was traced back to milk powder supplied via Dairy Farmers of America.

Cracks in the supply chain

In all these cases, the contaminations were traced to upstream ingredient suppliers, rather than the manufacturers’ own production lines. It’s this weakness in the supply chain that meant so many brands were affected, as suppliers often work with multiple brands.

For Nestle and Danone, the contamination was traced back to Arachidonic Acid Oil (ARA) imported from China, whereas in the US, the Clostridium Botulinum toxin was found to have come from an organic whole milk powder.

All of this has shone a bright light on ingredient-level traceability and the importance of having cast-iron food safety processes in place. So much so, that the European Commission is introducing new controls for the import of ARA oil from China, requiring it to be fully sampled and tested before entering the EU.

As food manufacturers extend global supply chains for cost efficiency, contamination risk becomes more distributed, and is therefore harder to catch early. This breach was caught in December 2025, but some reports suggest contaminated batches could have been on sale from as early as October that year.

Speed and transparency under the microscope

While the move to introduce new regulations is welcome, the speed at which manufacturers raised the alarm, and how they handled their response, is also under scrutiny.

Some consumer protection groups have questioned the transparency of Nestlé's process, with foodwatch Netherlands alleging that Dutch authorities were first informed about contamination in early December 2025, yet public recalls only began the first week of January - weeks later.

Austrian authorities also suggested Nestlé conducted a "silent" recall over the Christmas period before issuing public warnings.

Nestle and another provider, Lactalis, are now the subject of legal action brought by consumer group Foodwatch. The complaint at the centre of their case hinges on the time it took for a public recall to be issued.

In the US, the FDA found recalled ByHeart products still on shelves at major retailers weeks after the recall was issued, prompting the agency to send warning letters to four retailers for non-compliance.

Manufacturers must now take a close look at their recall and escalation procedures. Any bottlenecks or points of failure meaning an escalation is delayed even by hours, could carry a huge risk to consumers, reputation and future revenue. Proactive, fast and transparent communication is now a baseline expectation and the sector can expect tighter rules going forward.

Broader implications for food manufacturers and retailers.

Although these high-profile cases involving baby formula have shone a spotlight on that particular sector, the recent recalls have wide-ranging implications across food and retail industries.

1. You’re only ever as safe as your weakest supplier. All of these recalls originated from suppliers to the manufacturers. Robust supplier qualification, ingredient testing and contractual accountability are essential for producers looking for efficiency without compromise.
2. Recall readiness must be practiced, not assumed. The FDA's frustration with retailers who failed to pull product highlights how recall plans break down in the real world. Across Europe, producers now face potential legal proceedings over questions about recall delays. Manufacturers must own the full recall chain, including retail compliance, and retailers must police their own compliance tightly.
3. Regulatory scrutiny is intensifying. EFSA's new cereulide limits and FDA's increased focus on infant formula safety point to a broader regulatory tightening of high-vulnerability food categories. Proving compliance beyond a doubt will become increasingly important.
4. Consumer trust is a fragile asset. Parents reported being confused and shocked that contamination could happen in products they had been repeatedly told to trust. Brand recovery after a recall in a category like infant nutrition is long and difficult. With new parents already worrying about how they feed their children, the reputational stakes are uniquely high.
5. Documentation and traceability are your defence. Full sequencing played a critical role in both of these investigations. Companies that invest in traceability and rapid reporting infrastructure are better positioned to respond quickly and limit liability.

These two recalls tell the same story, even if the details are different.

Different contaminants, different countries, different producers, but the same weak points: suppliers that didn’t test fully enough, contaminants that slipped through and recalls that moved too slowly.

Every food manufacturer should be asking themselves whether their systems would hold up under the same pressure. If it can happen in one of the most tightly regulated food categories in the world, no manufacturer can afford to be complacent.

Sources:

1. Food Standards Agency (FSA) https://www.food.gov.uk/news-alerts/alert/fsa-prin-02-2026
2. FDA.gov https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-infant-botulism-infant-formula-november-2025
3. Chemical & Engineering News (ACS) https://cen.acs.org/safety/consumer-safety/toxin-Nestls-recalled-infant-formula/104/web/2026/01
4. Food Safety News https://www.foodsafetynews.com/2026/01/nestle-expands-infant-formula-recall/
5. Foodwatch https://www.foodwatch.org/en/global-recall-of-nestle-baby-food-foodwatch-criticizes-lack-of-transparency-from-nestle-and-food-authorities
6. Food Ingredients First https://www.foodingredientsfirst.com/news/nestle-infant-formula-recall-cereulide.html
7. Euronews https://www.euronews.com/health/2026/01/22/global-baby-formula-recall-nestle-danone-lactalis-pull-products-after-toxin-alert
8. Food Manufacture https://www.foodmanufacture.co.uk/Article/2026/01/26/nestle-recall-legal-transparency-timeliness-and-trust-restoration-after-a-global-safety-failure/
9. IBFAN https://www.ibfan.org/nestles-credibility-questioned-recall-2026/